ATP7A and rheumatoid arthritis: Induction of senescence to favour wound healing and induce resolution of fibrosis or chronic inflammatory conditions like rheumatoid arthritis may require less toxic approaches like the recently discovered pro-senescence activity of MC1-selective agonists [34], acting via the activation of a highly druggable GPCR which ligands have been shown to be safe in clinical trials.